Manulife (Manufacturers Life Insurance)’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-13,933
| Closed | -$390K | – | 3257 |
|
|
2022
Q1 | $390K | Sell |
13,933
-3,379
| -20% | -$92.6K | ﹤0.01% | 2346 |
|
|
2021
Q4 | $473 | Sell |
17,312
-272
| -2% | -$7.37K | ﹤0.01% | 2295 |
|
|
2021
Q3 | $478K | Sell |
17,584
-2,558
| -13% | -$63.3K | ﹤0.01% | 2324 |
|
|
2021
Q2 | $344K | Buy |
20,142
+844
| +4% | +$15.8K | ﹤0.01% | 2711 |
|
|
2021
Q1 | $403K | Sell |
19,298
-427
| -2% | -$9.85K | ﹤0.01% | 2429 |
|
|
2020
Q4 | $452K | Buy |
19,725
+276
| +1% | +$5.25K | ﹤0.01% | 2262 |
|
|
2020
Q3 | $317K | Sell |
19,449
-610
| -3% | -$11K | ﹤0.01% | 2254 |
|
|
2020
Q2 | $258K | Buy |
20,059
+176
| +0.9% | +$2.05K | ﹤0.01% | 2353 |
|
|
2020
Q1 | $236K | Buy |
19,883
+1,294
| +7% | +$28.7K | ﹤0.01% | 2224 |
|
|
2019
Q4 | $463K | Sell |
18,589
-787
| -4% | -$15.9K | ﹤0.01% | 2091 |
|
|
2019
Q3 | $321K | Sell |
19,376
-5
| -0% | -$91 | ﹤0.01% | 2282 |
|
|
2019
Q2 | $441K | Sell |
19,381
-361
| -2% | -$9.74K | ﹤0.01% | 2126 |
|
|
2019
Q1 | $635K | Buy |
19,742
+1,383
| +8% | +$42.8K | ﹤0.01% | 1947 |
|
|
2018
Q4 | $518K | Sell |
18,359
-1,333
| -7% | -$39K | ﹤0.01% | 1941 |
|
|
2018
Q3 | $566K | Sell |
19,692
-2,210
| -10% | -$66.4K | ﹤0.01% | 2191 |
|
|
2018
Q2 | $820K | Buy |
21,902
+2,140
| +11% | +$84K | ﹤0.01% | 2017 |
|
|
2018
Q1 | $777K | Sell |
19,762
-597
| -3% | -$21.8K | ﹤0.01% | 2000 |
|
|
2017
Q4 | $659K | Buy |
20,359
+438
| +2% | +$13.1K | ﹤0.01% | 2133 |
|
|
2017
Q3 | $620K | Sell |
19,921
-564
| -3% | -$16.7K | ﹤0.01% | 2120 |
|
|
2017
Q2 | $573K | Sell |
20,485
-928
| -4% | -$21K | ﹤0.01% | 2186 |
|
|
2017
Q1 | $368K | Buy |
21,413
+2,438
| +13% | +$34.1K | ﹤0.01% | 2400 |
|
|
2016
Q4 | $230K | Buy |
18,975
+760
| +4% | +$9.84K | ﹤0.01% | 2672 |
|
|
2016
Q3 | $289K | Sell |
18,215
-242
| -1% | -$3.65K | ﹤0.01% | 2475 |
|
|
2016
Q2 | $239K | Buy |
18,457
+6,988
| +61% | +$109K | ﹤0.01% | 2582 |
|
|
2016
Q1 | $212K | Buy |
11,469
+690
| +6% | +$12.5K | ﹤0.01% | 2559 |
|
|
2015
Q4 | $243 | Hold |
10,779
| – | – | ﹤0.01% | 2502 |
|
|
2015
Q3 | $252 | Buy |
10,779
+1,115
| +12% | +$30.8K | ﹤0.01% | 2464 |
|
|
2015
Q2 | $277 | Buy |
9,664
+6,457
| +201% | +$169K | ﹤0.01% | 2578 |
|
|
2015
Q1 | $83 | Buy |
3,207
+1,647
| +106% | +$37.7K | ﹤0.01% | 3225 |
|
|
2014
Q4 | $29 | Buy |
+1,560
| New | +$28.1K | ﹤0.01% | 3329 |
|
Manulife (Manufacturers Life Insurance)'s XENT Position: Q2 2022 in Review
Manulife (Manufacturers Life Insurance) sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 13,933 shares — an estimated $390K sold.
Manulife (Manufacturers Life Insurance) first reported a position in XENT in Q4 2014 and held it in 30 quarters. The position peaked at $820K in Q2 2018. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- Manulife (Manufacturers Life Insurance) reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 13,933 Intersect ENT, Inc shares in Q2 2022, an estimated $390K.
- Manulife (Manufacturers Life Insurance) first reported a position in Intersect ENT, Inc in Q4 2014 and held it in 30 quarters.
- Manulife (Manufacturers Life Insurance)'s Intersect ENT, Inc position peaked at $820K in Q2 2018.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2022, filed 15 Aug 2022.